Science, technology and culture gif

Investors

Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

GSK reaches agreement to acquire TESARO

On 3 December 2018 we announced our agreement to acquire TESARO, an oncology-focused company based in the US for approximately $5.1bn.

Find out more

Latest information

2018 Third quarter results announcement

We announced our third quarter results for the period ended 30 September 2018 on Wednesday 31 October.

Find out more